Quince Therapeutics, Inc.
QNCX
DELAYED 1 MONTH

1 insider filing · Latest: May 18, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 18, 2026Jun 11 9:30 PMBrigette RobertsDirector, Chief Corp. Affairs Officer
Grant/Award
16,698,162$0.846,837,319(D)

View →